The focal adhesion protein Integrin-Linked Kinase (ILK) as an important player in breast cancer pathogenesis

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
   PubMed Web of Science ®Google Scholar
• Chavez-MacGregor M, Mittendorf EA, Clarke CA, et al. Incorporating tumor characteristics to the american joint committee on cancer breast cancer staging system. Oncologist. 2017;22:1292–1300.
   PubMed Web of Science ®Google Scholar
• Rakha EA, Reis-Filho JS, Baehner F, et al. Breast cancer prognostic classification in the molecular era: the role of histological grade. Breast Cancer Res. 2010;12:207.
   PubMed Web of Science ®Google Scholar
• Cowell CF, Weigelt B, Sakr RA, et al. Progression from ductal carcinoma in situ to invasive breast cancer: revisited. Mol Oncol. 2013;7:859–869.
   PubMed Web of Science ®Google Scholar
• Pickup MW, Mouw JK, Weaver VM. The extracellular matrix modulates the hallmarks of cancer. EMBO Rep. 2014;15:1243–1253.
   PubMed Web of Science ®Google Scholar
• Wu C. ILK interactions. J Cell Sci. 2001;114:2549–2550.
   PubMed Web of Science ®Google Scholar
• Widmaier M, Rognoni E, Radovanac K, et al. Integrin-linked kinase at a glance. J Cell Sci. 2012;125:1839–1843.
   PubMed Web of Science ®Google Scholar
• Yoganathan N, Yee A, Zhang Z, et al. Integrin-linked kinase, a promising cancer therapeutic target: biochemical and biological properties. Pharmacol Ther. 2002;93:233–242.
   PubMed Web of Science ®Google Scholar
• Legate KR, Montanez E, Kudlacek O, et al. ILK, PINCH and parvin: the tIPP of integrin signalling. Nat Rev Mol Cell Biol. 2006;7:20–31.
   PubMed Web of Science ®Google Scholar
• McDonald PC, Fielding AB, Dedhar S. Integrin-linked kinase – essential roles in physiology and cancer biology. J Cell Sci. 2008;121:3121–3132.
   PubMed Web of Science ®Google Scholar
• Delcommenne M, Tan C, Gray V, et al. Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc Natl Acad Sci U S A. 1998;95:11211–11216.
   PubMed Web of Science ®Google Scholar
• Wu C. The PINCH-ILK-parvin complexes: assembly, functions and regulation. Biochim Biophys Acta. 2004;1692:55–62.
   PubMed Web of Science ®Google Scholar
• Nikolopoulos SN, Turner CE. Integrin-linked kinase (ILK) binding to paxillin LD1 motif regulates ILK localization to focal adhesions. J Biol Chem. 2001;276:23499–23505.
   PubMed Web of Science ®Google Scholar
• Wickstrom SA, Lange A, Montanez E, et al. The ILK/PINCH/parvin complex: the kinase is dead, long live the pseudokinase! Embo J. 2010;29:281–291.
   PubMed Web of Science ®Google Scholar
• Qian Y, Zhong X, Flynn DC, et al. ILK mediates actin filament rearrangements and cell migration and invasion through PI3K/Akt/Rac1 signaling. Oncogene. 2005;24:3154–3165.
   PubMed Web of Science ®Google Scholar
• Qu Y, Hao C, Xu J, et al. ILK promotes cell proliferation in breast cancer cells by activating the PI3K/Akt pathway. Mol Med Rep. 2017;16:5036–5042.
   PubMed Web of Science ®Google Scholar
• Attwell S, Mills J, Troussard A, et al. Integration of cell attachment, cytoskeletal localization, and signaling by integrin-linked kinase (ILK), CH-ILKBP, and the tumor suppressor PTEN. Mol Biol Cell. 2003;14:4813–4825.
   PubMed Web of Science ®Google Scholar
• Persad S, Attwell S, Gray V, et al. Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells. Proc Natl Acad Sci U S A. 2000;97:3207–3212.
   PubMed Web of Science ®Google Scholar
• Hannigan GE, McDonald PC, Walsh MP, et al. Integrin-linked kinase: not so ‘pseudo’ after all. Oncogene. 2011;30:4375–4385.
   PubMed Web of Science ®Google Scholar
• Serrano I, McDonald PC, Lock F, et al. Inactivation of the Hippo tumour suppressor pathway by integrin-linked kinase. Nat Commun. 2013;4:2976.
   PubMed Web of Science ®Google Scholar
• Sarbassov DD, Guertin DA, Ali SM, et al. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science. 2005;307:1098–1101.
   PubMed Web of Science ®Google Scholar
• McDonald PC, Oloumi A, Mills J, et al. Rictor and integrin-linked kinase interact and regulate Akt phosphorylation and cancer cell survival. Cancer Res. 2008;68:1618–1624.
   PubMed Web of Science ®Google Scholar
• Troussard AA, Tan C, Yoganathan TN, et al. Cell-extracellular matrix interactions stimulate the AP-1 transcription factor in an integrin-linked kinase- and glycogen synthase kinase 3-dependent manner. Mol Cell Biol. 1999;19:7420–7427.
   PubMed Web of Science ®Google Scholar
• Oloumi A, McPhee T, Dedhar S. Regulation of E-cadherin expression and beta-catenin/Tcf transcriptional activity by the integrin-linked kinase. Biochim Biophys Acta. 2004;1691:1–15.
   PubMed Web of Science ®Google Scholar
• Deng JT, Sutherland C, Brautigan DL, et al. Phosphorylation of the myosin phosphatase inhibitors, CPI-17 and PHI-1, by integrin-linked kinase. Biochem J. 2002;367:517–524.
   PubMed Web of Science ®Google Scholar
• Qin J, Wu C. ILK: a pseudokinase in the center stage of cell-matrix adhesion and signaling. Curr Opin Cell Biol. 2012;24:607–613.
   PubMed Web of Science ®Google Scholar
• Hanks SK, Quinn AM, Hunter T. The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science. 1988;241:42–52.
   PubMed Web of Science ®Google Scholar
• Boudeau J, Miranda-Saavedra D, Barton GJ, et al. Emerging roles of pseudokinases. Trends Cell Biol. 2006;16:443–452.
   PubMed Web of Science ®Google Scholar
• Elad N, Volberg T, Patla I, et al. The role of integrin-linked kinase in the molecular architecture of focal adhesions. J Cell Sci. 2013;126:4099–4107.
   PubMed Web of Science ®Google Scholar
• Horton ER, Humphries JD, James J, et al. The integrin adhesome network at a glance. J Cell Sci. 2016;129:4159–4163.
   PubMed Web of Science ®Google Scholar
• Dougherty GW, Chopp T, Qi SM, et al. The Ras suppressor Rsu-1 binds to the LIM 5 domain of the adaptor protein PINCH1 and participates in adhesion-related functions. Exp Cell Res. 2005;306:168–179.
   PubMed Web of Science ®Google Scholar
• Attwell S, Roskelley C, Dedhar S. The integrin-linked kinase (ILK) suppresses anoikis. Oncogene. 2000;19:3811–3815.
   PubMed Web of Science ®Google Scholar
• Gil D, Ciolczyk-Wierzbicka D, Dulinska-Litewka J, et al. The mechanism of contribution of integrin linked kinase (ILK) to epithelial-mesenchymal transition (EMT). Adv Enzyme Regul. 2011;51:195–207.
   PubMedGoogle Scholar
• Xing Y, Qi J, Deng S, et al. Small interfering RNA targeting ILK inhibits metastasis in human tongue cancer cells through repression of epithelial-to-mesenchymal transition. Exp Cell Res. 2013;319:2058–2072.
   PubMed Web of Science ®Google Scholar
• Serrano I, McDonald PC, Lock FE, et al. Role of the integrin-linked kinase (ILK)/Rictor complex in TGFbeta-1-induced epithelial-mesenchymal transition (EMT). Oncogene. 2013;32:50–60.
   PubMed Web of Science ®Google Scholar
• McPhee TR, McDonald PC, Oloumi A, et al. Integrin-linked kinase regulates E-cadherin expression through PARP-1. Dev Dyn. 2008;237:2737–2747.
   PubMed Web of Science ®Google Scholar
• Somasiri A, Howarth A, Goswami D, et al. Overexpression of the integrin-linked kinase mesenchymally transforms mammary epithelial cells. J Cell Sci. 2001;114:1125–1136.
   PubMed Web of Science ®Google Scholar
• Oloumi A, Maidan M, Lock FE, et al. Cooperative signaling between Wnt1 and integrin-linked kinase induces accelerated breast tumor development. Breast Cancer Res. 2010;12:R38.
   PubMed Web of Science ®Google Scholar
• Pontier SM, Huck L, White DE, et al. Integrin-linked kinase has a critical role in ErbB2 mammary tumor progression: implications for human breast cancer. Oncogene. 2010;29:3374–3385.
   PubMed Web of Science ®Google Scholar
• Yang J, Hou Y, Zhou M, et al. Twist induces epithelial-mesenchymal transition and cell motility in breast cancer via ITGB1-FAK/ILK signaling axis and its associated downstream network. Int J Biochem Cell Biol. 2016;71:62–71.
   PubMed Web of Science ®Google Scholar
• Riaz A, Zeller KS, Johansson S. Receptor-specific mechanisms regulate phosphorylation of AKT at Ser473: role of RICTOR in beta1 integrin-mediated cell survival. PLoS One. 2012;7:e32081.
   PubMed Web of Science ®Google Scholar
• Sepulveda JL, Wu C. The parvins. Cell Mol Life Sci. 2006;63:25–35.
   PubMed Web of Science ®Google Scholar
• Mongroo PS, Johnstone CN, Naruszewicz I, et al. Beta-parvin inhibits integrin-linked kinase signaling and is downregulated in breast cancer. Oncogene. 2004;23:8959–8970.
   PubMed Web of Science ®Google Scholar
• Acconcia F, Manavathi B, Mascarenhas J, et al. An inherent role of integrin-linked kinase-estrogen receptor alpha interaction in cell migration. Cancer Res. 2006;66:11030–11038.
   PubMed Web of Science ®Google Scholar
• Abboud ER, Coffelt SB, Figueroa YG, et al. Integrin-linked kinase: a hypoxia-induced anti-apoptotic factor exploited by cancer cells. Int J Oncol. 2007;30:113–122.
   PubMed Web of Science ®Google Scholar
• Chou CC, Chuang HC, Salunke SB, et al. A novel HIF-1alpha-integrin-linked kinase regulatory loop that facilitates hypoxia-induced HIF-1alpha expression and epithelial-mesenchymal transition in cancer cells. Oncotarget. 2015;6:8271–8285.
   PubMedGoogle Scholar
• Troussard AA, McDonald PC, Wederell ED, et al. Preferential dependence of breast cancer cells versus normal cells on integrin-linked kinase for protein kinase B/Akt activation and cell survival. Cancer Res. 2006;66:393–403.
   PubMed Web of Science ®Google Scholar
• Santos ND, Habibi G, Wang M, et al. Urokinase-type Plasminogen Activator (uPA) is Inhibited with QLT0267 a Small Molecule Targeting Integrin-linked Kinase (ILK). Transl Oncogenomics. 2007;2:85–97.
   PubMedGoogle Scholar
• Kalra J, Warburton C, Fang K, et al. QLT0267, a small molecule inhibitor targeting integrin-linked kinase (ILK), and docetaxel can combine to produce synergistic interactions linked to enhanced cytotoxicity, reductions in P-AKT levels, altered F-actin architecture and improved treatment outcomes in an orthotopic breast cancer model. Breast Cancer Res. 2009;11:R25.
   PubMed Web of Science ®Google Scholar
• Kalra J, Anantha M, Warburton C, et al. Validating the use of a luciferase labeled breast cancer cell line, MDA435LCC6, as a means to monitor tumor progression and to assess the therapeutic activity of an established anticancer drug, docetaxel (Dt) alone or in combination with the ILK inhibitor, QLT0267. Cancer Biol Ther. 2011;11:826–838.
   PubMed Web of Science ®Google Scholar
• Kalra J, Sutherland BW, Stratford AL, et al. Suppression of Her2/neu expression through ILK inhibition is regulated by a pathway involving TWIST and YB-1. Oncogene. 2010;29:6343–6356.
   PubMed Web of Science ®Google Scholar
• Lee SL, Chou CC, Chuang HC, et al. Functional role of mTORC2 versus integrin-linked kinase in mediating Ser473-Akt phosphorylation in PTEN-negative prostate and breast cancer cell lines. PLoS One. 2013;8:e67149.
   PubMed Web of Science ®Google Scholar
• Sreepadmanabh M, Toley BJ. Investigations into the cancer stem cell niche using in-vitro 3-D tumor models and microfluidics. Biotechnol Adv. 2018;36:1094–1110.
   PubMed Web of Science ®Google Scholar
• Pang MF, Siedlik MJ, Han S, et al. Tissue stiffness and hypoxia modulate the integrin-linked kinase ILK to control breast cancer stem-like cells. Cancer Res. 2016;76:5277–5287.
   PubMed Web of Science ®Google Scholar
• Hsu EC, Kulp SK, Huang HL, et al. Function of integrin-linked kinase in modulating the stemness of IL-6-abundant breast cancer cells by regulating gamma-secretase-mediated notch1 activation in caveolae. Neoplasia. 2015;17:497–508.
   PubMed Web of Science ®Google Scholar
• Hsu EC, Kulp SK, Huang HL, et al. Integrin-linked kinase as a novel molecular switch of the IL-6-NF-kappaB signaling loop in breast cancer. Carcinogenesis. 2016;37:430–442.
   PubMed Web of Science ®Google Scholar
• White DE, Cardiff RD, Dedhar S, et al. Mammary epithelial-specific expression of the integrin-linked kinase (ILK) results in the induction of mammary gland hyperplasias and tumors in transgenic mice. Oncogene. 2001;20:7064–7072.
   PubMed Web of Science ®Google Scholar
• Yang HJ, Zheng YB, Ji T, et al. Overexpression of ILK1 in breast cancer associates with poor prognosis. Tumour Biol. 2013;34:3933–3938.
   PubMedGoogle Scholar
• Akrida I, Nikou S, Gyftopoulos K, et al. Expression of EMT inducers integrin-linked kinase (ILK) and ZEB1 in phyllodes breast tumors is associated with aggressive phenotype. Histol Histopathol. 2018;33:937–949.
   PubMed Web of Science ®Google Scholar
• Chen P, Shen WZ, Karnik P. Suppression of malignant growth of human breast cancer cells by ectopic expression of integrin-linked kinase. Int J Cancer. 2004;111:881–891.
   PubMed Web of Science ®Google Scholar